Organigram Global (OGI) EBIT: 2018-2021
Historic EBIT for Organigram Global (OGI) over the last 3 years, with May 2021 value amounting to -$12.2 million.
- Organigram Global's EBIT rose 87.70% to -$12.2 million in Q2 2021 from the same period last year, while for May 2021 it was $169.6 million, marking a year-over-year increase of 233.71%. This contributed to the annual value of -$10.9 million for FY2025, which is 57.15% up from last year.
- According to the latest figures from Q2 2021, Organigram Global's EBIT is -$12.2 million, which was up 58.27% from -$29.3 million recorded in Q1 2021.
- Organigram Global's EBIT's 5-year high stood at $239.3 million during Q3 2020, with a 5-year trough of -$99.3 million in Q2 2020.
- Its 3-year average for EBIT is $3.0 million, with a median of -$11.8 million in 2019.
- The largest annual percentage gain for Organigram Global's EBIT in the last 5 years was 1,110.47% (2020), contrasted with its biggest fall of 18,420.13% (2020).
- Quarterly analysis of 4 years shows Organigram Global's EBIT stood at $46.2 million in 2018, then crashed by 99.67% to $154,000 in 2019, then plummeted by 18,420.13% to -$28.2 million in 2020, then skyrocketed by 87.70% to -$12.2 million in 2021.
- Its last three reported values are -$12.2 million in Q2 2021, -$29.3 million for Q1 2021, and -$28.2 million during Q4 2020.